Obesity as a Neuroendocrine Disorder

• Published in: Archives of medical research Vol. 54; no. 8; p. 102896
• Main Authors: Ferreira-Hermosillo, Aldo, de Miguel Ibañez, Regina, Pérez-Dionisio, Enid Karina, Villalobos-Mata, Karen Alexandra
• Format: Journal Article
• Language: English
• Published: United States 01-12-2023
• Subjects: Neuropeptide Y; Appetite regulation; Obesity; Dopamine; Hypothalamus; Leptin
• ISSN: 0188-4409; 1873-5487
• DOI: 10.1016/j.arcmed.2023.102896

Obesity is one of the most prevalent diseases in the world. Based on hundreds of clinical and basic investigations, its etiopathogenesis goes beyond the simple imbalance between energy intake and expenditure. The center of the regulation of appetite and satiety lies in the nuclei of the hypothalamus where peripheral signals derived from adipose tissue (e.g., leptin), the gastrointestinal tract, the pancreas, and other brain structures, arrive. These signals are part of the homeostatic control system (eating to survive). Additionally, a hedonic or reward system (eating for pleasure) is integrated into the regulation of appetite. This reward system consists of a dopaminergic circuit that affects eating-related behaviors influencing food preferences, food desires, gratification when eating, and impulse control to avoid compulsions. These systems are not separate. Indeed, many of the hormones that participate in the homeostatic system also participate in the regulation of the hedonic system. In addition, factors such as genetic and epigenetic changes, certain environmental and sociocultural elements, the microbiota, and neuronal proinflammatory effects of high-energy diets also contribute to the development of obesity. Therefore, obesity can be considered a complex neuroendocrine disease, and all of the aforementioned components should be considered for the management of obesity.